Zenas BioPharma, Inc. is seeking a strategic leader for Global Publications, Scientific Communications, and Medical Information.
The role drives overarching communication strategy and publication planning across obexelimab and orelabrutinib, translating complex data into clear narratives for HCPs and regulators. The Executive Director will build a high-performing team, manage multi-year publication plans, and ensure compliant, timely data disclosures for Phase 1-3 results and regulatory
